Lack of Association between IFNL3 Polymorphism and Human Papillomavirus Infection and Their Progression in HIV-Infected Women Receiving Antiretroviral Treatment.

Background:It has been reported that interferon-lambda 3 (IFNL3)might influence the pathogenesis and clearance of human papillomavirus (HPV) infection. The impact ofIFNL3single-nucleotide polymorphism (SNP) on HPV infection is currently unknown. The aim of this study was to investigate the association between variants in theIFNL3region and HPV infection in women with human immunodeficiency virus (HIV) infection.Methods:A total of 236 HIV patients, including 65 HPV-negative and 171 HPV DNA-positive women, were enrolled into this study. TheIFNL3rs12979860 polymorphism was genotyped using a predesigned TaqMan SNP genotyping assay.Results:Data showed no significant differences in genotypes or allele frequencies between the HPV DNA-positive and the HPV-negative women (p> 0.05). After dividing the HPV-positive women according to cytology results into patients with abnormal and normal lesions, the genotype and allele distribution of the SNP did not significantly differ between the 2 groups (p> 0.05).Conclusions:Our results showed that theIFNL3rs12979860 polymorphism is not a major determinant of the susceptibility to HPV infection and their progression to abnormal cervical lesions in women living with HIV.